Sept 1 (Reuters) – Ultragenyx Pharmaceutical Inc. : * ULTRAGENYX ANNOUNCES THE PUBLICATION OF A SUCCESSFUL 96-WEEK RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH CROSSOVER TREATMENT OF GENGLYCOS™ (ALSO
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Mudryk joins Tottenham on loan from Chelsea
VIDEO SHOWS: RECENT & ARCHIVE OF MYKHAILO MUDRYK DURING TRAINING COMPLETE SCRIPT TO FOLLOW SHOWS:…
UPDATE 3-Bessent urges BOJ chief to combat weak yen with 'decisive' monetary steps
* Bessent met BOJ chief Ueda on Sunday, Treasury says * Bessent supports Japan's steps…
Anthropic resumes external cyber tests after Claude AI hacks
By Mrinmay Dey Aug 31 (Reuters) - Anthropic said on Monday it resumed external cybersecurity…
